Oncolytics lung cancer drug shrinks tumors in 92 percent of patients in trial (Reuters) - Oncolytics Biotech Inc said its cancer drug Reolysin reduced the size of tumors in 92 percent of lung cancer patients in a mid-stage trial. The company's shares rose as much as 22 percent to $3.22 in trading before the bell. The drug was tested on patients suffering from advanced squamous cell carcinoma of the lung. It was used intravenously in combination with chemotherapy drugs ...
Sept. 9, 2013 - Reuters via Yahoo! News
Roach: Carcinoid tumor usually benign Dear Dr. Roach: I am confused. I was diagnosed with a neuroendocrine tumor in my rectum two years ago. When I asked if it was cancer, I was told no, it was a carcinoid. The tumor was successfully removed with TEMS surgery. When I went to the doctor's office recently (it wasn't my regular doctor), he read my chart and asked about my carcinoma. Was it cancer or not? Does having this tumor exclude ...
Sept. 9, 2013 - The Alexandria Town Talk